←Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic HCT, Haploidentical Transplant
Ephraim Fuchs
MD
🏢Johns Hopkins Sidney Kimmel Comprehensive Cancer Center🌐USA
Professor of Oncology
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ephraim Fuchs pioneered post-transplant cyclophosphamide (PTCy) for haploidentical HCT, transforming access to allogeneic transplant for patients without matched donors. His protocol is the backbone of modern haplo transplantation worldwide. He co-led BMT CTN trials comparing haplo to matched donors.
Share:
🧪Research Fields 研究领域
haploidentical HCT
post-transplant cyclophosphamide
GVHD prevention
BMT CTN 1703
allogeneic HCT
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ephraim Fuchs 的研究动态
Follow Ephraim Fuchs's research updates
留下邮箱，当我们发布与 Ephraim Fuchs（Johns Hopkins Sidney Kimmel Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment